Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)

The "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI) is a grant that does not permit clinical trials. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for research aimed at maturing nanotechnology-based cancer diagnostics and treatments. Advanced pre-clinical research applications that show a promising combination of nano-device construction and therapeutic or diagnostic content delivered through nanoparticles or nano-devices are particularly encouraged.

TTNCI grants are designed to facilitate the maturation of experimental nanomedicines and to enhance the effectiveness of cancer treatments. The overall objective is to evolve proposed nanotechnology-based interventions to a phase where they can proceed along a developmental journey towards the National Cancer Institute's Experimental Therapeutics (NExT) and other translation programs of NCI. These TTNCI awards are intended to help in further development and growth in this field of study.